Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

about

Evaluation of an investigational wearable injector in healthy human volunteers.

P2860

Q51108832-8785477D-F80C-4B5E-B975-2910062EFBD0

P2860

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

Item

http://www.wikidata.org/entity/Q48064606

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@en

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@nl

type

Item

label

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@en

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@nl

prefLabel

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@en

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@nl

P1476

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

@en

P2093

Kathrin Gerbershagen

http://www.w3.org/2001/XMLSchema#string

Volker Limmroth

http://www.w3.org/2001/XMLSchema#string

P2860

PEGylation of Interferon-β-1a

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.

Evidence for a two-stage disability progression in multiple sclerosis

Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.

The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

P304

1969-1978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2014.943181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25255732

http://www.w3.org/2001/XMLSchema#string

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

about

P2860

P2860

Single-use autoinjector for once-weekly intramuscular injection of IFNβ-1a.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698